HDAC inhibitors (Epi Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHDAC inhibitors (Epi Pharmaceuticals)
Drug Alias NameHDAC inhibitors (Cellgate)HDAC inhibitors (Progen Pharmaceuticals)histone deacetylase inhibitors (Progen Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitors
TargetsHistone deacetylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellgate
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpi Pharmaceuticals IncCellgateTbg Diagnostics
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A